Nanomix Past Earnings Performance
Past criteria checks 0/6
Nanomix's earnings have been declining at an average annual rate of -32.4%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 89.1% per year.
Key information
-32.4%
Earnings growth rate
82.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -89.1% |
| Return on equity | n/a |
| Net Margin | -81,114.2% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Nanomix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | -13 | 5 | 3 |
| 30 Sep 22 | 0 | -12 | 5 | 3 |
| 30 Jun 22 | 0 | -10 | 4 | 4 |
| 31 Mar 22 | 0 | -11 | 4 | 3 |
| 31 Dec 21 | 0 | -9 | 3 | 3 |
| 30 Sep 21 | 0 | -9 | 2 | 3 |
| 30 Jun 21 | 0 | -8 | 2 | 3 |
| 31 Mar 21 | 0 | -6 | 1 | 4 |
| 31 Dec 20 | 1 | -6 | 1 | 4 |
| 31 Dec 19 | 0 | -6 | 1 | 4 |
Quality Earnings: NNMX is currently unprofitable.
Growing Profit Margin: NNMX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if NNMX's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare NNMX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NNMX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.7%).
Return on Equity
High ROE: NNMX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.